Stephanie Robinson
BBA, JD
Clinical Trial Coordinator
I am a Clinical Trial Coordinator in the Oxford Primary Care Clinical Trials Unit where I support the set-up, recruitment, and day-to-day running of clinical trials. I am currently working on DEFINE which is looking to find out whether using the FeNO (fractional exhaled nitric oxide) test during asthma reviews can help improve care for asthma patients and SuMMiT-D which is investigating the use of a digital system that uses text messages to support people with type 2 diabetes. I joined the CTU in May 2014 and have worked on a variety of trials within the cardiovascular and infectious diseases themes.
Before joining the CTU, I worked at the John Radcliffe Hospital as a research administrator for the National Institute for Health Research (NIHR) Clinical Research Network, working on various studies in dementias and neurodegenerative diseases.
I originally trained and worked in accounting and law in the United States, but had a career change to healthcare research upon moving to the UK in 2009.
Recent publications
-
Supporting people with type 2 diabetes in effective use of their medicine through mobile health technology integrated with clinical care (SuMMiT-D pilot): results of a feasibility randomised trial
Journal article
Farmer AJ. et al, (2024), Pilot and Feasibility Studies, 10
-
supporting people with type 2 diabetes diabetes in effective use of their medicine through mobile health technology integrated with clinical care (SuMMiT-D pilot): results of a feasibility randomised trial
Journal article
FARMER A., (2024), Pilot and Feasibility Studies
-
Supporting People With Type 2 Diabetes in the Effective Use of Their Medicine Through Mobile Health Technology Integrated With Clinical Care to Reduce Cardiovascular Risk: Protocol for an Effectiveness and Cost-effectiveness Randomized Controlled Trial
Journal article
Farmer A. et al, (2022), JMIR Research Protocols, 11
-
Supporting people with type 2 diabetes in effective use of their medicine through mobile health technology integrated with clinical care to reduce cardiovascular risk (SuMMiT-D): an effectiveness and cost-effectiveness randomised control trial protocol
Journal article
FARMER A. et al, (2021), JMIR Research Protocols
-
Supporting People With Type 2 Diabetes in the Effective Use of Their Medicine Through Mobile Health Technology Integrated With Clinical Care to Reduce Cardiovascular Risk: Protocol for an Effectiveness and Cost-effectiveness Randomized Controlled Trial (Preprint)
Preprint
Farmer A. et al, (2021)